Bryan Renk of BioForward

Bryan Renk of BioFoward gives a preview of the Aug. 25 Biotechology Vision Summit. Plus, we have the Wisconsin stock report for mid-August and commentary from Wisconsin Technology Council President Tom Still reflecting on the business impact on the first human clinical trial involving embryonic stem cells.

Printer-friendly version      Send this article to a friend      Share

Close Window